UBS Maintains Buy on Constellium, Lowers Price Target to $32
UBS analyst Alex Stansbury maintains Constellium (NYSE:CSTM) with a Buy and lowers the price target from $34 to $32.
Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
UBS analyst Alex Stansbury maintains Constellium (NYSE:CSTM) with a Buy and lowers the price target from $34 to $32.
Wells Fargo analyst Timna Tanners maintains Constellium (NYSE:CSTM) with a Overweight and lowers the price target from $39 to $38.